Suppr超能文献

缅甸(缅甸)最大的抗逆转录病毒治疗方案的治疗结果:扩大规模后保留的队列分析。

Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.

机构信息

Imperial College London, London, United Kingdom.

出版信息

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e53-62. doi: 10.1097/QAI.0b013e31824d5689.

Abstract

BACKGROUND

Antiretroviral treatment (ART) coverage in Myanmar is well below average. This study describes retention and baseline predictors of prognosis from the largest ART program in the country.

METHODS

A cohort analysis of adult patients who initiated ART during 2003-2007 was conducted, with follow-up until the end of 2009. The primary outcome was attrition [death plus losses to follow-up (LTF)]. Baseline variables were assessed as potential risk factors. The cumulative probabilities of death, LTF, and attrition up to 5 years were described using Kaplan-Meier estimates. Cox regression was used to calculate hazard ratios of attrition, overall and separately for 2 time periods on ART: 1-6 and 7-36 months.

RESULTS

A total of 5963 adults enrolled in the program, providing 17,581 person-years of follow-up. Median age at baseline was 33 years [interquartile range (IQR): 28-38], 61% were men, 45% were in World Health Organization stage IV, and the median CD4 count was 71 cells per cubic millimeter (IQR: 29-164). There were 821 (13.8%) deaths and 389 (6.5%) LTF over the study period, with a 72% probability of being retained in care in the 5-year cohort. Double the rate of loss was contributed by death compared with LTF, and attrition was almost 4 times higher in the period 1-6 months compared with 7-36 months. In the multivariable analyses of the program overall, older age [adjusted hazard ratio (aHR): 1.56, 95% confidence interval (CI): 1.25 to 1.94], being male (aHR: 1.52, 95% CI: 1.25 to 1.85), World Health Organization stage IV (aHR: 1.44, 95% CI: 1.19 to 1.74), and body mass index <16 kg/m² (aHR: 2.13, 95% CI: 1.71 to 2.66) were independently predictive of attrition.

CONCLUSIONS

The excellent retention over >6 years in this large cohort demonstrates that ART delivery at the primary care level in Myanmar is feasible and should encourage support for further ART expansion in the country.

摘要

背景

缅甸的抗逆转录病毒治疗(ART)覆盖率远低于平均水平。本研究描述了该国最大的 ART 项目中保留和预后的基线预测因素。

方法

对 2003-2007 年间开始接受 ART 的成年患者进行队列分析,并随访至 2009 年底。主要结局是失访[死亡加失访(LTF)]。评估基线变量作为潜在的危险因素。使用 Kaplan-Meier 估计描述了截至 5 年的死亡率、LTF 和失访的累积概率。使用 Cox 回归计算了失访的风险比,总体和分别在 ART 的两个时间段:1-6 个月和 7-36 个月。

结果

共有 5963 名成年人参加了该计划,提供了 17581 人年的随访。基线时的中位年龄为 33 岁[四分位间距(IQR):28-38],61%为男性,45%处于世界卫生组织(WHO)IV 期,中位 CD4 计数为 71 个细胞/立方毫米(IQR:29-164)。研究期间有 821 人(13.8%)死亡和 389 人(6.5%)LTF,在 5 年的队列中,有 72%的人保留在护理中。死亡导致的失访率是 LTF 的两倍,1-6 个月的失访率几乎是 7-36 个月的 4 倍。在对整个项目的多变量分析中,年龄较大(调整后的风险比[aHR]:1.56,95%置信区间[CI]:1.25 至 1.94)、男性(aHR:1.52,95%CI:1.25 至 1.85)、WHO 期 IV(aHR:1.44,95%CI:1.19 至 1.74)和 BMI<16 kg/m²(aHR:2.13,95%CI:1.71 至 2.66)是独立预测失访的因素。

结论

在这个大型队列中,超过 6 年的出色保留率表明,在缅甸基层医疗中提供抗逆转录病毒治疗是可行的,这应该鼓励支持该国进一步扩大抗逆转录病毒治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验